Dr. Genova is an industry thought leader with an extensive background focused on delivering ... Inc., and Vice President at GSK plc (formerly GlaxoSmithKline plc) and Kos Pharmaceuticals, Inc ...

NEW YORK CITY, NY / ACCESS Newswire / March 28, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...

GSK exited Kenya in 2023 as part of its restructuring and now supplies its medicines and vaccines through a third-party distributor. Be part of an exclusive group of enthusiasts! Get fresh content ...

NEW YORK, NY / ACCESS Newswire / March 27, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...

Meanwhile, in its annual report published on Thursday, British drugmaker GSK (NYSE:GSK) said it would no longer set "aspirational targets"—in reference to DEI initiatives—for leadership and ...

Multinational pharmaceutical company GSK’s commitment to invest up to $800 million in its facility near Marietta may have gone elsewhere without tax incentives approved by local officials last year.

and stressed that the settlements have been agreed "with no admission of liability." If pushed over the line, the settlements substantially resolve an issue that has been hanging over GSK for more ...

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...

GSK has claimed its second breakthrough designation ... a rare form of bone cancer with no FDA-approved treatments. The coveted status can help speed up the development and regulatory review ...